Scroll to Content

NWPHARMATECH

is a Clinical Stage Biotech Company with a Focus on Psychiatric & Neurological Disorders

NWPharmaTech’s expert team combines academic research, cutting-edge technology and clinical development to bring to market new drug formulations targeting mental health conditions.

These therapeutic interventions will support a return to homeostasis, empowering patients to lead longer and healthier lives.

Initial Target Indications – Psychiatric and Neurological Disorders
We are advancing to late-stage clinic development in Clinical High Risk for Psychosis, as well as Phase II trials elsewhere within the CNS space.

Our Work

Patented Drug Formulation Platform

A new generation of drug delivery technology

Our patented drug delivery technology unlocks superior bioavailability and thus better therapeutic potential and lower COGS.

Target Diseases in Clinical Development

Our Drug Pipeline

We are advancing to late-stage clinic development in Clinical High Risk for Psychosis, as well as Phase II trials elsewhere within the CNS space.

OUR TEAM

We are a driven team of specialists, committed to advancing research in Psychiatric and Neurological Disorders. Our team has experience across multiple sectors – pharmaceutical operations, research and development, intellectual property, marketing and finance – and is based in the UK, Europe and North America.

Our Partners

We are powered by a passionate team and partners - spanning prestigious learnings institutions, R&D companies, and clinical centres.

R&D

Universities

Clinical

We aim to achieve our goals with scientific rigour and an evidence-based approach, utilising the latest technologies that are emerging in the pharmaceutical sector in pre-clinical development, clinical validation, drug formulation and drug delivery mechanisms.

CONTACT US

0203 693 3791
team@nwpharmatech.com


OUR HEADOFFICE

Beaufort Gardens
London SW3 1PW
United Kingdom